Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice

[1]  B. Neel,et al.  Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2. , 2014, Cell metabolism.

[2]  F. Haj,et al.  Disruption of protein-tyrosine phosphatase 1B expression in the pancreas affects β-cell function. , 2014, Endocrinology.

[3]  M. Watt,et al.  High-fat-fed obese glutathione peroxidase 1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage. , 2014, Antioxidants & redox signaling.

[4]  S. Griffey,et al.  Pancreatic T cell protein-tyrosine phosphatase deficiency ameliorates cerulein-induced acute pancreatitis , 2014, Cell Communication and Signaling.

[5]  P. Yue,et al.  Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts , 2012, Proceedings of the National Academy of Sciences.

[6]  B. Neel,et al.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice , 2012, Diabetologia.

[7]  M. Tremblay,et al.  T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. , 2011, The Journal of clinical investigation.

[8]  P. Marchetti,et al.  PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Pancreatic β-Cell Apoptosis via Regulation of the BH3-Only Protein Bim , 2011, Diabetes.

[9]  B. Neel,et al.  Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. , 2011, Cell metabolism.

[10]  C. Mathews,et al.  Progressive Erosion of β-Cell Function Precedes the Onset of Hyperglycemia in the NOD Mouse Model of Type 1 Diabetes , 2011, Diabetes.

[11]  F. Haj,et al.  Differential Regulation of Endoplasmic Reticulum Stress by Protein Tyrosine Phosphatase 1B and T Cell Protein Tyrosine Phosphatase* , 2011, The Journal of Biological Chemistry.

[12]  T. Ørntoft,et al.  STAT1 Is a Master Regulator of Pancreatic β-Cell Apoptosis and Islet Inflammation* , 2010, The Journal of Biological Chemistry.

[13]  B. Wicksteed,et al.  Conditional Gene Targeting in Mouse Pancreatic β-Cells , 2010, Diabetes.

[14]  M. Tremblay,et al.  T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis , 2010, Diabetes.

[15]  G. Radda,et al.  Glucose intolerance and impaired insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas. , 2010, Endocrinology.

[16]  B. Wicksteed,et al.  Conditional Gene Targeting in Mouse Pancreatic-Cells Analysis of Ectopic Cre Transgene Expression in the Brain , 2010 .

[17]  D. Lawrence,et al.  Acquisition of a potent and selective TC-PTP inhibitor via a stepwise fluorophore-tagged combinatorial synthesis and screening strategy. , 2009, Journal of the American Chemical Society.

[18]  G. Feng,et al.  Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic β-cells , 2009, Proceedings of the National Academy of Sciences.

[19]  A. Yoshiki,et al.  Genetic differences among C57BL/6 substrains. , 2009, Experimental animals.

[20]  M. Bugliani,et al.  PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Interferon-γ–Induced Pancreatic β-Cell Apoptosis , 2009, Diabetes.

[21]  M. Bugliani,et al.  PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma- induced pancreatic beta-cell apoptosis Running title: PTPN2 regulates cytokine-induced β-cell death. , 2009 .

[22]  M. Bugliani,et al.  PTPN 2 , a candidate gene for type 1 diabetes , modulates interferon-gamma-induced pancreatic beta-cell apoptosis , 2009 .

[23]  T. Tiganis,et al.  Cell cycle-dependent regulation of SFK, JAK1 and STAT3 signaling by the protein tyrosine phosphatase TCPTP , 2008, Cell cycle.

[24]  Kun Wook Chung,et al.  Essential Role for Signal Transducer and Activator of Transcription-1 in Pancreatic β-Cell Death and Autoimmune Type 1 Diabetes of Nonobese Diabetic Mice , 2007, Diabetes.

[25]  D. Levy,et al.  JAK-STAT Signaling: From Interferons to Cytokines* , 2007, Journal of Biological Chemistry.

[26]  A. Bennett,et al.  Protein tyrosine phosphatase function: the substrate perspective. , 2007, The Biochemical journal.

[27]  I. Lossos,et al.  T-Cell Protein Tyrosine Phosphatase, Distinctively Expressed in Activated-B-Cell-Like Diffuse Large B-Cell Lymphomas, Is the Nuclear Phosphatase of STAT6 , 2007, Molecular and Cellular Biology.

[28]  C. Kahn,et al.  From mice to men: insights into the insulin resistance syndromes. , 2006, Annual review of physiology.

[29]  Ji-yeon Lee,et al.  The transcription factor Stat3 is dispensable for pancreatic beta-cell development and function. , 2005, Biochemical and biophysical research communications.

[30]  K. Kaestner,et al.  The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion , 2005 .

[31]  M. Tremblay,et al.  Selective regulation of tumor necrosis factor–induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase , 2005, Nature Immunology.

[32]  K. Kaestner,et al.  The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. , 2005, The Journal of clinical investigation.

[33]  S. Akira,et al.  Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. , 2004, Biochemical and biophysical research communications.

[34]  J. Richardson,et al.  Essential Role of STAT3 in Body Weight and Glucose Homeostasis , 2004, Molecular and Cellular Biology.

[35]  F. Haj,et al.  Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. , 2004, Diabetes.

[36]  N. Tonks,et al.  Regulation of Insulin Receptor Signaling by the Protein Tyrosine Phosphatase TCPTP , 2003, Molecular and Cellular Biology.

[37]  B. Wicksteed,et al.  Insulin Secretory Deficiency and Glucose Intolerance in Rab3A Null Mice* , 2003, The Journal of Biological Chemistry.

[38]  M. Stoffel,et al.  β-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass , 2002, Nature Genetics.

[39]  M. Tremblay,et al.  The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3 , 2002, Current Biology.

[40]  M. Stoffel,et al.  beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. , 2002, Nature genetics.

[41]  N. Aoki,et al.  A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. , 2002, Molecular endocrinology.

[42]  Yu-Rong Fu,et al.  Identification of a Nuclear Stat 1 Protein Tyrosine Phosphatase , 2002 .

[43]  Hyung-Lae Kim,et al.  Requirement for the L-type Ca2+ channel α1D subunit in postnatal pancreatic β cell generation , 2001 .

[44]  M. Jackerott,et al.  Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. , 2001, Diabetes.

[45]  P. Suh,et al.  Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation. , 2001, The Journal of clinical investigation.

[46]  C. Kahn,et al.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. , 2000, Molecular cell.

[47]  M. Magnuson,et al.  Analysis of the Cre‐mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas , 2000, Genesis.

[48]  Y. Kido,et al.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. , 2000, The Journal of clinical investigation.

[49]  C. Dina,et al.  Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[50]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[51]  Danhong Lu,et al.  A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. , 1999, The Journal of clinical investigation.

[52]  N. Tonks,et al.  Epidermal Growth Factor Receptor and the Adaptor Protein p52Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase , 1998, Molecular and Cellular Biology.

[53]  M. Birnbaum,et al.  Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2 , 1998, Nature Genetics.

[54]  N. Tonks,et al.  Epidermal Growth Factor Receptor and the Adaptor Protein p 52 Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase , 1998 .

[55]  John Wagner,et al.  Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.

[56]  Y. Yazaki,et al.  Analysis of the Pancreatic β Cell in the Mouse with Targeted Disruption of the Pancreatic β Cell-Specific Glucokinase Gene , 1996 .

[57]  Y. Yazaki,et al.  Analysis of the pancreatic beta cell in the mouse with targeted disruption of the pancreatic beta cell-specific glucokinase gene. , 1996, Biochemical and biophysical research communications.